The success of Viagra initially drove a period of growth for the drug industry, however recent developments present a complicated scenario for shareholders. Off-patent competitors are eroding revenue, and continued https://marleypfaz048310.blogolenta.com/38223455/the-blue-pill-and-big-pharma-a-volatile-investment